Brain Cancer Diagnostic Market Detailed Analysis and Forecast up to 2028
The “Brain Cancer Diagnostic Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Diagnostic Type, Cancer Type, End User, Tumor Size, and Geography," the market is expected to reach US$ 7,378.57 million in 2028 from US$ 1,639.10 million in 2022; it is estimated to grow at a CAGR of 28.5.% during 2022–2028. The report highlights the key factors driving the brain cancer diagnostic market growth and prominent players with their developments in the brain cancer diagnostic market.
Brain cancers are caused due to extracellular growth of the cells in the brain that causes tumors. The tumor includes primary brain tumors and secondary brain tumors. Primary brain tumors are formed in the brain and do not spread to other body parts, whereas secondary tumors, also known as metastases, are those cancers that began in another part of the body. Brain tumors are categorized into 40 major types that are further classified into two major groups. Benign tumor is slow-growing and have less possibility to spread, and malignant tumor is cancerous and more likely to spread. The growth of the brain cancer diagnostics market is primarily attributed to the rising incidence of brain cancer and an increasing number of cigarette smokers worldwide. However, the high cost of brain tumor diagnosis restricts the market growth.
Brain cancers are caused due to extracellular growth of the cells in the brain that causes tumors. The tumor includes primary brain tumors and secondary brain tumors. Primary brain tumors are formed in the brain and do not spread to other body parts, whereas secondary tumors, also known as metastases, are those cancers that began in another part of the body.
Get FREE Sample Copy @
Key factors driving the growth of this market are the increase in brain cancer worldwide and the rise in cigarette smokers is expected to drive the market during the forecast period. However, the high cost of brain tumor diagnosis hampers the brain cancer diagnostics market growth.
The brain cancer diagnostics market is majorly comprised of top players involving
THERMO FISHER SCIENTIFIC INC,
Siemens Healthineers AG,
GE Healthcare,
MDxHealth,
NantOmics,
Biocept, Inc.,
Koninklijke
Philips N.V.,
Canon Medical Systems,
Hitachi, Ltd.,
The companies listed above are implementing various strategies such as product launches, acquisitions, mergers, and partnerships, which have resulted in the company's growth and, in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
About Us:
“The Insight Partners” is a one-stop solution for all industrial research requirements. We help our clients get quick solutions pertaining to the market scenario and requirements based on our state-of-the-art research methodology. We excel at providing research-based reports across a wide range of sectors and industries such as Semiconductors & Electronics, Aerospace & Defense, Automotive & Transportation, Biotechnology, Healthcare, IT, Manufacturing & Construction, Medical Device Technology, Media & Telecommunications, and Chemicals & Materials.
We keep our research pattern lucid to understand. Serving the best to our customers is our foremost priority. Our research reports time and again have proved to be value for the money of clients providing the most suitable data and market analysis.
Our research work precisely focuses on the market performance in terms of market size, competitive plotting, company analysis, regional or country analysis, etc. We deliver the categorically segmented data that provides the know-how of geography, products & services, thereby, enabling the clients to better understand their industrial research requirements.
Contact Us:
If you have any queries pertaining to the report or would like further information, feel free to reach out to us at-
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
